Drug
Avatrombopag clinical trials
Also written E5501, Doptelet and AKR-501.
- studies test it
- 51
- open now
- 12
- in phase 3
- 14
- first study started
- 2007
Keep track of what changes. Save the avatrombopag studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
51 studies that test it; most in 2021 (10)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 10 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 9
- Phase 2
- 22
- Phase 3
- 14
- Phase 4
- 5
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 25 · Other 26
Eisai Inc. (16) · Institute of Hematology & Blood Diseases Hospital, China (9) · Sobi, Inc. (6) · Peking Union Medical College Hospital (3) · Eisai Co., Ltd. (2) · Hanny Al-Samkari, MD (1) · Anhui Provincial Cancer Hospital (1) · Swedish Orphan Biovitrum (1)
Often tested with
Tested in the same studies.
Fluconazole (1) · Itraconazole (1) · Rifampin (1) · Tretinoin (1) · Rituximab (1) · Platelet Transfusion (1) · Medication (1)
Studies
Open first, then newest update. How each study uses avatrombopag is read from its arms, and is right about nine times in ten.
Testing it · 51
- A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard TreatmentNot yet recruitingPhase 2/3Swedish Orphan BiovitrumNCT07786922Written as Avatrombopag 20 mg Oral Tablet
- Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune ThrombocytopeniaNot yet recruitingPhase 2/3Institute of Hematology & Blood Diseases Hospital, ChinaNCT07278908Written as Avatrombopag+All trans retinoic acid
- The Holistic StudyNot yet recruitingPhase 3Ostfold Hospital TrustNCT07051915Written as Avatrombopag
- Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot StudyRecruitingPhase 4Al-Mustansiriyah UniversityNCT07133659Written as Avatrombopag 20 mg Oral Tablet
- Avatrombopag for Chemotherapy-induced ThrombocytopeniaRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT05218226Written as Avatrombopag
- Avatrombopag in the Treatment of Pediatric Immune ThrombocytopeniaRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06281327Written as Avatrombopag
- Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With AutoantibodiesRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT04993885Written as Avatrombopag
- Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCTRecruitingPhase 2/3Peking University People's HospitalNCT06202625Written as avatrombopag
- Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAANot yet recruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06254287Written as Avatrombopag
- Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the ElderlyRecruitingPhase 2Peking Union Medical College HospitalNCT06004752Written as Avatrombopag
- Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAICRecruitingPhase 2Second Affiliated Hospital of Guangzhou Medical UniversityNCT06001567Written as Avatrombopag
- The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AARecruitingNot applicableInstitute of Hematology & Blood Diseases Hospital, ChinaNCT05518331Written as avatrombopag
- Avatrombopag vs. Placebo for CIT in GI MalignanciesCompletedPhase 2Hanny Al-Samkari, MDNCT05772546Written as Avatrombopag
- Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 MonthsCompletedPhase 3Sobi, Inc.NCT04516967Written as Avatrombopag
- Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITPCompletedPhase 3Sobi, Inc.NCT05369208Written as Avatrombopag Oral Tablet
- Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or RomiplostimCompletedPhase 4Sobi, Inc.NCT04638829Written as Avatrombopag Oral Tablet
- Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)WithdrawnEarly Phase 1University of RochesterNCT04931849Written as Avatrombopag
- Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological CancersCompletedPhase 3Sobi, Inc.NCT03471078Written as Avatrombopag
- Avatrombopag Combined With IST as First-line Treatment for SAAStatus unknownPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT05720234Written as avatrombopag
- Avatrombopag to Promote Platelet Engraftment After Allo-HSCTStatus unknownPhase 2The First Affiliated Hospital of Soochow UniversityNCT05143892Written as Avatrombopag
See all 51 studies that test avatrombopag →
Given in every arm · 1 — avatrombopag is usual care beside what is tested
Codes
What other systems call avatrombopag · ClinicalTrials.gg INT005355
- MeSH (NLM) C533238avatrombopagConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3H8GSZ4SQLAVATROMBOPAGConfirmed FDA, NLM, Wikidata
- RxNorm 2045726One source FDA
- Wikidata Q27257213avatrombopagConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C150559AvatrombopagOne source FDA
- DrugBank DB11995One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C533238 | avatrombopag | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3H8GSZ4SQL | AVATROMBOPAG | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2045726 | — | One source FDA |
| Wikidata | Q27257213 | avatrombopag | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C150559 | Avatrombopag | One source FDA |
| DrugBank | DB11995 | — | One source Wikidata |
Also registered as avatrombopag maleate (UNII GDW7M2P1IS · RxNorm 2045727).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.